Actively Recruiting
Study Comparing the BTL Emsella Chair to Sham Treatment for Male Sexual and Ejaculatory Dysfunction
Led by Corewell Health East · Updated on 2026-07-09
117
Participants Needed
1
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
The trial investigates the use of the Emsella Chair, a high intensity focused electromagnetic HIFEM device, for treating male sexual dysfunction, especially ejaculatory dysfunction EjD and erectile dysfunction ED. Male sexual health issues like EjD are common and impact quality of life. Current treatments have limitations, and this study aims to assess whether the Emsella Chair provides symptom improvement compared to a sham treatment. The study is conducted in two phases. Phase 1 is an open-label pilot with 10 male participants receiving active treatment. If results suggest improvement, phase 2 will be a double-blind randomized trial comparing active Emsella Chair treatment to sham. Participants sit on the device while settings are adjusted to their sensory threshold. The sham treatment provides limited sensation below therapeutic levels. A total of up to 117 men may be enrolled across both phases. Participants will undergo eight treatments and complete questionnaires measuring sexual function and symptom changes. Assessments include the Global Response Assessment and Male Sexual Health Questionnaire at baseline and follow-up visits 4 weeks after treatment. Safety and tolerability will also be monitored for up to 24 weeks. The trial is expected to complete by December 2028, with continuous evaluation of symptom improvement and side effects.
CONDITIONS
Brief Title
Emsella Chair vs Sham for Male Sexual Dysfunction
Research Team
J
Jo Medado-Ramirez, BSN
J
Jennifer Giordano, BSN
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here